Publication

Abstract : Blood cancer is a life-threatening disease, and detecting it at an early stage is critical for improving treatment outcomes and survival rates. Timely diagnosis plays a key role in managing the condition effectively and increasing the chances of recovery. In this research, we have introduced a sensor specifically engineered for early-stage blood cancer detection, utilizing a combination of graphene, silver, and magnesium fluoride (MgF₂) materials. This design leverages the unique properties of these materials to enhance sensitivity, reliability, and overall performance in biomedical diagnostic applications. A maximum sensitivity of 1428 nm/RIU was obtained through the application of parametric optimization, which significantly enhanced the sensor’s performance by fine-tuning its design parameters for improved responsiveness to changes in the refractive index of the target medium. This ultra-sensitive sensor is engineered for the detection of blood cancer and tailored for diverse biomedical applications. It enables precise diagnostics, advancing early disease identification and therapeutic strategies. Its sensitive design enhances accuracy, making it invaluable in clinical research, laboratory settings, and medical diagnostic procedures.